Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » Advocacy » Unicorn Foundation invited to speak at the first INCA/ENETs symposium

Unicorn Foundation invited to speak at the first INCA/ENETs symposium

  • January 18, 2017
On Friday 10th March the European Neuroendocrine Tumor Society (ENETS) and the International Neuroendocrine Cancer Alliance (INCA) will hold the first patient-physician symposium Unmet Needs in NET Care and Research: Priorities for Actions at the annual ENETS Scientific Meeting in Barcelona, Spain.

Unicorn Foundation CEO and INCA board member Simone Leyden has been invited to speak at the symposium on the "Unmet Needs" from the patient perspective. We are very grateful to ENETS President Prof Massimo Falconi and the advisory committee for their progressive view of including patients and patient groups within the highly respected ENETs program. This inclusion is reflective of the long and hard work of past and present INCA members and presidents and we are grateful to all those who have contributed over the years to make this possible.

We look forward to the meeting and reporting back to our UF friends on what the priorities will be moving forward, to better the outcomes for NET patients in Australia and around the world.

 

Share this post

Recent posts

Sydney NET Patient Forum Brings Together Patients and Clinicians

October 28, 2025

Patient and Consumer Roundtable on Comparator Selection in HTA

October 27, 2025

Racing for a Cure 2025

October 27, 2025

NECA Highlights Gaps in Government’s Senate Inquiry Response

October 16, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousThe loss of a true patient champion
NextAustralia’s National Patient & Carer Organisation Standing CommitteeNext

Related Posts

Patient and Consumer Roundtable on Comparator Selection in HTA

On Monday 27 October our CEO attended a face to face Patient and Consumer Roundtable in Canberra with 10 other not-for-profit organisation. The Roundtable was

NECA Highlights Gaps in Government’s Senate Inquiry Response

After 458 days of waiting, the Government finally released its response to the Senate  Inquiry into Rare and Less Common Cancers, including Neuroendocrine Cancer, on

PCPA Cancer Summit

  The Private Cancer Physicians of Australia (PCPA) hosted its Annual Meeting: Cancer Summit 2025 in Sydney on 13 September, bringing together clinicians, researchers, and

SCAN 2025 is now open – we need your voice

SCAN 2025 is now open – we need your voice.  As a proud member of the International Neuroendocrine Cancer Alliance (INCA), NeuroEndocrine Cancer Australia is excited

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin